Coronavirus hasn't developed resistance to Paxlovid, but can that last?; health officials raise monkeypox awareness ahead of Pride Month

As Paxlovid becomes more widely available, some researchers fear we may be using it in ways that raise the risk of resistant strain emerging. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      Coronavirus hasn't developed resistance to Paxlovid. How long can that last? By Jason Mast Adobe Resistance is the hobgoblin of antiviral medicine, even with antivirals as effective as Paxlovid. Read More Health officials scramble to raise monkeypox awareness ahead of Pride Month By Helen Branswell Octavio Jones/Getty Images Officials are seeking to get out the message that monkeypox may be a risk to men who have sex with men, without stigmatizing the community. Read More STAT+: Key Senate committee proposes a council to ensure FDA better coordinates on accelerated approvals By Lev Facher Jessica Rinaldi/The Boston Globe Key senators want to create a council meant to help the FDA sidestep some of the issues that plagued its approval of Aduhelm. Read More Sponsor content by YouTube Guide for influencers with tips on how to share mental health stories to help reduce stigma Global rates of those experiencing mental health issues are on the rise. YouTube and the National Alliance of Mental Illness have worked together to build resources for video creators with tips on how to speak from personal experience and collaborate with experts to help normalize mental health. Learn more. On the lookout for monkeypox, CDC considers expanding test capacity By Andrew Joseph Jessica McGowan/Getty Images While many labs can test for the viral family that includes monkeypox, only the CDC can currently confirm the specific type. Read More STAT+: ViiV will make it easier for generic companies to copy its HIV prevention shot, but it's not clear when By Ed Silverman C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus/CDC This is a long overdue step, said Jessica Burry of Doctors Without Borders. But it will still take years before generics are available. Read More An emergency doctor and parent sorts through Covid vaccine options for kids under 5 By Adam Feuerstein and Meg Tirrell JEFF KOWALSKY/AFP via Getty Images STAT sat down Jeremy Faust, an emergency physician and a dad of a kid under 5 who's sorting through all of this himself. Read More STAT+: The World Health Assembly moves to bolster clinical trials, but some say it falls short By Ed Silverman “There were some missed opportunities,” said Francisco Viegas, a medical policy advisor to Doctors Without Borders. Read More Friday, May 27, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser